» A new study led by McGill University researchers shows that artificial intelligence (AI) analysis of blood samples can predict and explain disease progression in neurodegenerative diseases such as Alzheimer’s and Huntington’s disease, which could one day help physicians choose more appropriate and effective treatments for patients. Their research describing the algorithm was published in Brain: A Journal of Neurology.
» U.S. healthcare organizations are increasingly recognizing that a welcoming, inclusive staff culture is crucial in serving the lesbian, gay, bisexual and queer patient population, yet less than half of healthcare organizations today are capturing sexual orientation and gender identity information from patients, and even fewer (33%) have policies specific to transgender patients, a poll conducted at AHIMA ’19 found. Making changes in how health information technology systems collect, process, safeguard and manage patients’ protected health information can improve care and lead to better outcomes, according to an article in the Journal of AHIMA.
» Chinese researchers have developed color-changing bandages that can sense drug-resistant and drug-sensitive bacteria in wounds and treat them accordingly. The team found that the bandage could speed the healing of wounds in mice that were infected with drug-sensitive or drug-resistant bacteria. Findings are published in ACS Central Science.
» Digital therapeutics company Biofourmis and medical device company ImagineMIC have announced a partnership to drive improvement outcomes and lower healthcare costs for patients with chronic conditions. The first stage of the collaboration will involve the remote monitoring of cardiac arrhythmias among thousands of SNF and subacute care program patients with chronic conditions.
» The U.S. Food & Drug Administration has approved patient-specific airway stents developed by a Cleveland Clinic physician that are designed using CT scans and proprietary 3D visualization software. The lung stents enable the opening of airways for individuals with serious breathing disorders.
